Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care.

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist (2013) 2.55

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Res Treat (2013) 1.27

A rare case of malignant solitary fibrous tumor of the spinal cord. Spine (Phila Pa 1976) (2008) 1.18

αB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res (2013) 1.02

NSCLC and HER2: between lights and shadows. J Thorac Oncol (2014) 0.91

Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer. PLoS One (2013) 0.89

Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma. Oral Oncol (2004) 0.88

Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. J Cell Biochem (2012) 0.88

Triple-negative breast cancer: an update on neoadjuvant clinical trials. Int J Breast Cancer (2012) 0.86

Stratifying triple-negative breast cancer: which definition(s) to use? Breast Cancer Res (2011) 0.85

Gefitinib in lung cancer therapy: clinical results, predictive markers of response and future perspectives. Cancer Biol Ther (2009) 0.83

The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. Oncology (2013) 0.82

Emerging targeted therapies for castration-resistant prostate cancer. Front Endocrinol (Lausanne) (2012) 0.81

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study. Radiat Oncol (2011) 0.81

Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients. Expert Opin Pharmacother (2008) 0.81

Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: two case reports. Cancer Biol Ther (2012) 0.80

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients. Oncol Rep (2011) 0.78

IL-33/IL-31 axis: a new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity. J Cell Biochem (2013) 0.77

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS One (2015) 0.77

ERRATUM: Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity. Sci Rep (2015) 0.75

Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? J Am Acad Dermatol (2008) 0.75

Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient. Future Oncol (2014) 0.75